Patents by Inventor Ya-fang Mei

Ya-fang Mei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral compounds
    Patent number: 8993622
    Abstract: The present invention provides new antiviral compounds and pharmacological compositions comprising these new compounds and their use in the prophylaxis, prevention and treatment of viral infections, particularly adenovirus and herpes virus infections.
    Type: Grant
    Filed: June 13, 2011
    Date of Patent: March 31, 2015
    Assignee: Eirium AB
    Inventors: Göran Wadell, Karin Edlund, Marten Strand, Emma Andersson, Christopher Öberg, Mikael Elofsson, Ya-Fang Mei
  • ANTIVIRAL COMPOUNDS
    Publication number: 20130210915
    Abstract: The present invention provides new antiviral compounds and pharmacological compositions comprising these new compounds and their use in the prophylaxis, prevention and treatment of viral infections, particularly adenovirus and herpes virus infections.
    Type: Application
    Filed: June 13, 2011
    Publication date: August 15, 2013
    Inventors: Göran Wadell, Karin Edlund, Marten Strand, Emma Andersson, Christopher Öberg, Mikael Elofsson, Ya-Fang Mei
  • REPLICATING VIRAL VECTORS FOR GENE THERAPY
    Publication number: 20120283318
    Abstract: The present invention concerns the field of gene therapy and in particular the use of specific adenoviral vector systems for gene therapy, said vector systems offering enhanced efficiency and specificity for gene delivery. More specifically, the present invention provides replicating-competent adenoviral vector systems carrying one or more inserted heterologous gene. The adenoviral vectors system according to the invention are characterized by high binding efficiency and infectivity to cells of neural origin, endothelial cells, carcinoma cells and dendritic cells.
    Type: Application
    Filed: October 4, 2010
    Publication date: November 8, 2012
    Inventors: Ya-Fang Mei, Goran Wadell
  • Viral vectors for gene therapy
    Patent number: 7459153
    Abstract: Adenovirus types 11p and 4p show a higher binding affinity and infectivity than type 5 for endothelial and carcinoma cell lines. Adenovirus type 11p shows a stronger binding to cells for neural origin, such as glioblastoma, neuroblastoma and medulloblastoma. The fact that adenovirus type 11 has a comparatively low prevalence in society, together with its high affinity and infectivity, makes it very suitable for use in gene therapy.
    Type: Grant
    Filed: January 4, 2002
    Date of Patent: December 2, 2008
    Inventors: Göran Wadell, Ya-fang Mei, Anna Segerman, Johan Skog, Kristina Lindman
  • Viral vectors for gene therapy
    Publication number: 20040136958
    Abstract: Adenovirus types 11p and 4p show a higher binding affinity and infectivity than type 5 for endothelial and carcinoma cell lines. Adenovirus type 11p shows a stronger binding to cells for neural origin, such as glioblastoma, neuroblastoma and medulloblastoma. The fact that adenovirus type 11 has a comparatively low prevalence in society, together with its high affinity and infectivity, makes it very suitable for use in gene therapy.
    Type: Application
    Filed: January 23, 2004
    Publication date: July 15, 2004
    Inventors: Goran Wadell, Ya-fang Mei, Anna Segerman, Johan Skog, Kristina Lindman